|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 282.85 USD | -2.26% |
|
-6.67% | -28.87% |
Chart calendar Alnylam Pharmaceuticals, Inc.
Upcoming events on Alnylam Pharmaceuticals, Inc.
| 2026-06-25 | Information meeting | 11:00 am |
| 2026-09-17 | Information meeting | 10:30 am |
| 2026-10-26 | Information meeting | 10:00 am |
Past events on Alnylam Pharmaceuticals, Inc.
| 2026-05-20 | Présentation aux Actionnaires / Analystes | 10:30 am |
| 2026-05-20 | Annual General Meeting | 10:30 am |
| 2026-04-30 | Earnings presentation | 08:30 am |
| 2026-04-30 | Earnings release - Q1 2026 | |
| 2026-03-24 | Information meeting | 09:30 am |
| 2026-02-12 | Earnings release - Q4 2025 | |
| 2026-02-12 | Earnings presentation | 08:30 am |
| 2025-10-30 | Earnings release - Q3 2025 | |
| 2025-10-30 | Earnings presentation | 08:30 am |
| 2025-08-30 | Information meeting | 01:00 pm |
| 2025-07-31 | Earnings release - Q2 2025 | |
| 2025-07-31 | Earnings presentation | 08:30 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 828 1 827 0.1% | 2 248 2 235 0.57% | 3 714 3 774 -1.6% | 5 626 | 7 324 | 8 721 |
|
EBITDA Million USD | Released Forecast Spread | -228 -250 8.91% | -120 -66,4 -81.11% | 557 543 2.55% | 1 294 | 1 802 | 2 239 |
|
EBIT Million USD | Released Forecast Spread | -282 -275 -2.6% | -177 -127 -39.16% | 502 580 -13.48% | 1 290 | 1 842 | 2 408 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -434 -437 0.72% | -377 -254 -48.31% | 323 366 -11.6% | 1 164 | 1 730 | 2 309 |
|
Net income Million USD | Released Forecast Spread | -440 -441 0.12% | -278 -257 -8.18% | 314 316 -0.8% | 1 026 | 1 520 | 1 983 |
|
EPS USD | Released Forecast Spread | -3,52 -3,53 0.29% | -2,18 -2,01 -8.49% | 2,33 2,36 -1.35% | 7,70 | 10,9 | 14,2 |
| Announcement Date | 15/02/24 | 13/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 501 527 -4.95% | 593 581 2.16% | 594 581 2.23% | 774 662 16.79% | 1 249 974 28.22% | 1 097 1 157 -5.21% | 1 167 1 117 4.53% | 1 321 | 1 480 | 1 645 | 1 671 | 1 885 | 1 985 | 2 121 |
|
EBITDA Million USD | Released Forecast Spread | -62,9 -82,7 23.91% | -91,0 -56,1 -62.19% | 32,5 -107 130.36% | -2,26 -9,87 77.16% | 382 176 116.74% | 145 152 -4.66% | 282 153 85.04% | 255 | 337 | 383 | 286 | |||
|
EBIT Million USD | Released Forecast Spread | -76,9 -98,9 22.24% | -105 -57,2 -83.86% | 18,1 -102 117.8% | -16,2 -51,6 68.58% | 368 126 192.8% | 132 213 -38.1% | 269 142 88.91% | 279 | 338 | 396 | 387 | 397 | 406 | 517 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -109 -123 11.85% | -194 -67,0 -189.64% | -41,6 -130 67.91% | -35,4 -82,6 57.18% | 239 70,5 239.2% | 86,3 198 -56.33% | 222 126 76.23% | 254 | 309 | 378 | 407 | 356 | 381 | 490 |
|
Net income Million USD | Released Forecast Spread | -112 -123 9.38% | -83,8 -80,0 -4.69% | -57,5 -121 52.4% | -66,3 -80,4 17.57% | 251 61,9 305.72% | 112 175 -36.27% | 206 124 65.58% | 221 | 273 | 325 | 326 | 301 | 325 | 415 |
|
EPS USD | Released Forecast Spread | -0,87 -0,94 7.71% | -0,65 -0,59 -10.22% | -0,44 -1,01 56.22% | -0,51 -0,70 27.1% | 1,84 0,55 236.13% | 0,82 1,23 -33.24% | 1,51 0,91 66.61% | 1,66 | 2,03 | 2,37 | 2,32 | 2,41 | 2,59 | 3,12 |
| Announcement Date | 31/10/24 | 13/02/25 | 01/05/25 | 31/07/25 | 30/10/25 | 12/02/26 | 30/04/26 | - | - | - | - | - | - | - |
| Today | Information meeting | 09:00 am | |
| 2026-06-14 | Earnings presentation | 10:00 pm | |
| 2026-06-14 | Annual General Meeting | ||
| 2026-06-15 | Ex-dividend date - 0.82 USD | 12:00 am | |
| 2026-06-15 | Annual General Meeting | 12:00 pm | |
| 2026-06-15 | Extraordinary General Meeting | ||
| 2026-06-15 | Annual General Meeting | 02:00 am | |
| 2026-06-15 | Annual General Meeting | 09:00 pm | |
| 2026-06-15 | Ex-dividend date - 0.34 CNY | 12:00 am | |
| 2026-06-15 | Extraordinary General Meeting | 02:00 am |
Past sector events for Alnylam Pharmaceuticals, Inc.
| 2026-06-12 | Annual General Meeting | 03:30 am | |
| 2026-06-12 | Extraordinary General Meeting | 02:30 am | |
| 2026-06-12 | Ex-dividend date - 0.169 HKD | 12:00 am | |
| Today | Extraordinary General Meeting | ||
| 2026-06-12 | Extraordinary General Meeting | 02:00 am | |
| 2026-06-12 | Ex-dividend date - 0.35 CNY | 12:00 am | |
| 2026-06-12 | Extraordinary General Meeting | 02:30 am | |
| 2026-06-12 | Annual General Meeting | 12:00 pm | |
| 2026-06-12 | Ex-dividend date for special dividend - 0.03 HKD | 12:00 am | |
| 2026-06-12 | Ex-dividend date - 0.37 HKD | 12:00 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALNY Stock
- Calendar Alnylam Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















